• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于临床病理参数的IgA肾病辨证:一种决策树模型

Syndrome Differentiation of IgA Nephropathy Based on Clinicopathological Parameters: A Decision Tree Model.

作者信息

Gu Yanghui, Wang Yu, Ji Chunlan, Fan Ping, He Zhiren, Wang Tao, Liu Xusheng, Zou Chuan

机构信息

Renal Division, Second Clinical Medical College, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510006, China.

Renal Division, Shanxi Provincial Hospital of Chinese Medicine, Xi'an 710200, China.

出版信息

Evid Based Complement Alternat Med. 2017;2017:2697560. doi: 10.1155/2017/2697560. Epub 2017 Mar 26.

DOI:10.1155/2017/2697560
PMID:28458713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5385230/
Abstract

IgA nephropathy is the most common cause of primary glomerulonephritis in China, and Traditional Chinese Medicine (TCM) is a vital treatment strategy. However, not all doctors prescribing TCM medicine have adequate knowledge to classify the syndrome accurately. To explore the feasibility of differentiation of TCM syndrome types among IgA nephropathy patients based on clinicopathological parameters. The cross-sectional study enrolled 464 biopsy-proven IgA nephropathy adult patients from 2010 to 2016. The demographic data, clinicopathological features, and TCM syndrome types were collected, and the decision tree models based on classification and regression tree were built to differentiate between the syndrome types. 370 patients of training dataset were 32 years old with serum creatinine of 79 mol/L, estimated glomerular filtration rate (eGFR) of 97.2 mL/min/1.73 m, and proteinuria of 1.0 g/day. The scores of Oxford classifications were as follows: M1 = 97.6%, E1 = 14.6%, S1 = 50.0%, and T1 = 52.2%/T2 = 18.4%. The decision trees without or with MEST scores achieved equal precision in training data. However, the tree with MEST scores performed better in validation dataset, especially in classifying the syndrome of qi deficiency of spleen and kidney. A feasible method to deduce TCM syndromes of IgA nephropathy patients by common parameters in routine clinical practice was proposed. The MEST scores helped in the differentiation of TCM syndromes with clinical data.

摘要

IgA肾病是中国原发性肾小球肾炎最常见的病因,而中医是一种重要的治疗策略。然而,并非所有开中药的医生都有足够的知识来准确辨证。为了探讨基于临床病理参数对IgA肾病患者进行中医证型辨别的可行性。这项横断面研究纳入了2010年至2016年464例经活检证实的成年IgA肾病患者。收集了人口统计学数据、临床病理特征和中医证型,并建立了基于分类与回归树的决策树模型来区分证型。训练数据集的370例患者年龄为32岁,血清肌酐为79μmol/L,估计肾小球滤过率(eGFR)为97.2mL/min/1.73m²,蛋白尿为1.0g/天。牛津分类的评分如下:M1 = 97.6%,E1 = 14.6%,S1 = 50.0%,T1 = 52.2%/T2 = 18.4%。在训练数据中,不使用或使用MEST评分的决策树具有相同的精度。然而,带有MEST评分的树在验证数据集中表现更好,尤其是在脾肾气虚证型的分类方面。提出了一种在常规临床实践中通过常见参数推断IgA肾病患者中医证候的可行方法。MEST评分有助于结合临床数据区分中医证型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7b1/5385230/0c50caf75906/ECAM2017-2697560.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7b1/5385230/22b09ac8cb16/ECAM2017-2697560.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7b1/5385230/0c50caf75906/ECAM2017-2697560.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7b1/5385230/22b09ac8cb16/ECAM2017-2697560.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7b1/5385230/0c50caf75906/ECAM2017-2697560.002.jpg

相似文献

1
Syndrome Differentiation of IgA Nephropathy Based on Clinicopathological Parameters: A Decision Tree Model.基于临床病理参数的IgA肾病辨证:一种决策树模型
Evid Based Complement Alternat Med. 2017;2017:2697560. doi: 10.1155/2017/2697560. Epub 2017 Mar 26.
2
[Multicentered, randomized, controlled clinical trial on patients with IgA nephropathy of Qi-yin deficiency syndrome type].[IgA肾病气阴两虚证型患者的多中心、随机、对照临床试验]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Feb;27(2):101-5.
3
[A multi-centeric epidemiological survey on TCM syndrome in 1016 patients with IgA nephropathy and analysis of its relevant factors].[1016例IgA肾病患者中医证候多中心流行病学调查及其相关因素分析]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Mar;26(3):197-201.
4
Clinicopathological Characteristics and Impacts on Clinical Outcomes of Thrombotic Microangiopathy Lesions in Patients with Immunoglobulin A Nephropathy in Thailand.泰国免疫球蛋白 A 肾病患者血栓性微血管病病变的临床病理特征及其对临床结局的影响。
Am J Nephrol. 2023;54(7-8):308-318. doi: 10.1159/000531693. Epub 2023 Jul 10.
5
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.儿童和青年IgA肾病进展的危险因素:来自VALIGA欧洲队列的261例病例分析
Pediatr Nephrol. 2017 Jan;32(1):139-150. doi: 10.1007/s00467-016-3469-3. Epub 2016 Aug 25.
6
Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.能否预测IgA肾病的进展?IgA肾病进展计算器的验证及其在我们研究人群中与MEST-C评分的关系。
Nefrologia (Engl Ed). 2019 Sep-Oct;39(5):523-530. doi: 10.1016/j.nefro.2018.10.015. Epub 2019 Mar 20.
7
Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.中药(益气清解复方)联合免疫抑制疗法治疗 IgA 肾病患者终末期肾病高危风险(TCM-WINE)的疗效:一项随机对照试验的研究方案。
Trials. 2020 Jan 6;21(1):31. doi: 10.1186/s13063-019-3989-9.
8
Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.牛津分类法在确定IgA肾病免疫抑制治疗中的临床实用性。
Ann Med. 2017 May;49(3):217-229. doi: 10.1080/07853890.2016.1252058. Epub 2016 Nov 29.
9
Clinicopathologic Manifestations of Immunoglobulin A Nephropathy in a Northern Indian Cohort: A Mute Assassin with Delayed Diagnosis.印度北部队列中免疫球蛋白A肾病的临床病理表现:一个诊断延迟的隐匿杀手
Indian J Nephrol. 2023 Jan-Feb;33(1):12-21. doi: 10.4103/ijn.ijn_351_21. Epub 2022 Nov 21.
10
Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.印度一家三级医院原发性IgA肾病患者的临床和组织病理学特征
Ren Fail. 2016;38(3):431-6. doi: 10.3109/0886022X.2016.1138817. Epub 2016 Feb 2.

引用本文的文献

1
Machine learning-based diagnosis and prognosis of IgAN: A systematic review and meta-analysis.基于机器学习的IgA肾病诊断与预后:一项系统评价与荟萃分析。
Heliyon. 2024 Jun 14;10(12):e33090. doi: 10.1016/j.heliyon.2024.e33090. eCollection 2024 Jun 30.
2
Decision Tree-Based Body Constitution Diagnosis System for Traditional Chinese Medicine.基于决策树的中医体质诊断系统
Evid Based Complement Alternat Med. 2022 Mar 7;2022:5560087. doi: 10.1155/2022/5560087. eCollection 2022.
3
SDTM: A Novel Topic Model Framework for Syndrome Differentiation in Traditional Chinese Medicine.

本文引用的文献

1
A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy.一种基于系统生物学方法理解固本通络汤作用于IgA肾病分子机制的研究
BMC Complement Altern Med. 2016 Aug 24;16(1):312. doi: 10.1186/s12906-016-1268-9.
2
[Effect of "Gubentongluo Formula" on the IgA Class Switch Recombination of B Lymohocytes in Peyer's Patches in Mice with IgA Nephropathy].["固本通络方对IgA肾病小鼠派氏结B淋巴细胞IgA类别转换重组的影响"]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2016 May;47(3):337-41.
3
Study of TCM clinical records based on LSA and LDA SHTDT model.
SDTM:一种用于中医证候分类的新主题模型框架。
J Healthc Eng. 2022 Jan 4;2022:6938506. doi: 10.1155/2022/6938506. eCollection 2022.
4
Traditional Chinese Medicine in Treating IgA Nephropathy: From Basic Science to Clinical Research.中医治疗IgA肾病:从基础科学到临床研究
J Transl Int Med. 2021 Sep 28;9(3):161-167. doi: 10.2478/jtim-2021-0021. eCollection 2021 Sep.
5
Study of TCM Syndrome Identification Modes for Patients with Type 2 Diabetes Mellitus Based on Data Mining.基于数据挖掘的2型糖尿病患者中医辨证模式研究
Evid Based Complement Alternat Med. 2021 Sep 6;2021:5528550. doi: 10.1155/2021/5528550. eCollection 2021.
6
A New Method for Syndrome Classification of Non-Small-Cell Lung Cancer Based on Data of Tongue and Pulse with Machine Learning.基于舌象和脉象数据的机器学习在非小细胞肺癌中医证候分类中的应用
Biomed Res Int. 2021 Aug 11;2021:1337558. doi: 10.1155/2021/1337558. eCollection 2021.
基于潜在语义分析(LSA)和潜在狄利克雷分配短文本主题模型(LDA SHTDT)的中医临床记录研究
Exp Ther Med. 2016 Jul;12(1):288-296. doi: 10.3892/etm.2016.3285. Epub 2016 Apr 20.
4
The Efficacy of Shen Shuaining Capsule on Chronic Kidney Disease: A Systematic Review and Meta-Analysis.肾衰宁胶囊治疗慢性肾脏病的疗效:一项系统评价与Meta分析
Evid Based Complement Alternat Med. 2016;2016:7515413. doi: 10.1155/2016/7515413. Epub 2016 Feb 14.
5
Identification of Chinese medicine syndromes in persistent insomnia associated with major depressive disorder: a latent tree analysis.伴有重度抑郁症的持续性失眠的中医证候识别:潜树分析
Chin Med. 2016 Feb 12;11:4. doi: 10.1186/s13020-016-0076-y. eCollection 2016.
6
Honey in the Prevention and Treatment of Infection in the CKD Population: A Narrative Review.蜂蜜在慢性肾脏病患者感染防治中的应用:一项叙述性综述
Evid Based Complement Alternat Med. 2015;2015:261425. doi: 10.1155/2015/261425. Epub 2015 Jun 17.
7
Comparison of scoring methods for the Brief Insomnia Questionnaire in a general population sample.一般人群样本中简短失眠问卷评分方法的比较。
J Psychosom Res. 2015 Jan;78(1):34-8. doi: 10.1016/j.jpsychores.2014.11.015. Epub 2014 Nov 20.
8
Renal biopsy research in the former soviet union: prevention of a negligent custom.前苏联的肾活检研究:一种不良惯例的预防
ISRN Nephrol. 2012 Sep 4;2013:980859. doi: 10.5402/2013/980859. eCollection 2013.
9
Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'.对《KDIGO 2012慢性肾脏病评估与管理临床实践指南》的评论
Kidney Int. 2013 Sep;84(3):622-3. doi: 10.1038/ki.2013.243.
10
IgA nephropathy.IgA肾病
N Engl J Med. 2013 Jun 20;368(25):2402-14. doi: 10.1056/NEJMra1206793.